Neuronetics (NASDAQ:STIM) Given Market Perform Rating at Wil

William Blair reissued their market perform rating on shares of Neuronetics (NASDAQ:STIM – Free Report) in a research note published on Tuesday morning, RTT News reports. Separately, Piper Sandler reaffirmed an overweight rating and issued a $8.00 target price (up from $7.00) on shares of Neuronetics in a research note on Wednesday, March 6th. Read […]

Related Keywords

United States , William Blair , Piper Sandler , Keithj Sullivan , Kent Lake Capital , Neuronetics Inc , Neuronetics Company Profile , Nantahala Capital Management , Millrace Asset Group Inc , Securities Exchange Commission , Free Report , Get Free Report , Exchange Commission , Lake Capital , Capital Management , Asset Group , Divisadero Street Capital Management , Street Capital Management , Neurostar Advanced Therapy System , Neuronetics Daily ,